A new alliance between Sanofi and Google has been launched to improve care in people with type 1 and type 2 diabetes, the latest in a growing number of tie-ups between pharma and technology companies.

Sanofi India on Tuesday said it has launched its diabetes drug Soliqua in the country ... to improve glycemic control as an adjunct to diet and exercise, in those who are insufficiently controlled ...

Sanofi’s Lyxumia for type 2 diabetes has been granted marketing authorization ... and / or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control.

Sanofi–Aventis has signed an agreement with ... pancreatic islet neogenesis — for the treatment of type 1 and type 2 diabetes. The agreement for this preclinical-stage agent involves an ...

Sanofi, Breakthrough T1D UK, and Beano have partnered to create a bespoke comic strip to raise awareness of autoimmune Type 1 ...

Metabolex has entered into an agreement with Sanofi–Aventis for the development ... is in a Phase II trial for the treatment of type 2 diabetes (T2D). Metabolex will receive upfront and ...